Patent ID: 7445772
Filing Date: 2008-11-04
Classification: A61K,C07K,C12N,Y10S

Abstract:
1. A method of treating asthma comprising administering to a subject a therapeutically effective amount of a fusion protein selected from the group consisting of: (a) a first polypeptide comprising amino acid residues 1 to 156 of SEQ ID NO: 2 and a second polypeptide comprising amino acid residues of SEQ ID NO: 3 or SEQ ID NO: 4; (b) a first polypeptide comprising amino acid residues 6 to 156 of SEQ ID NO: 2 and a second polypeptide comprising amino acid residues of SEQ ID NO: 3 or SEQ ID NO: 4; and (c) a first polypeptide comprising amino acid residues 21 to 156 of SEQ ID NO: 2 and a second polypeptide comprising amino acid residues of SEQ ID NO: 3 or SEQ ID NO: 4.